Meghana Rao

Meghana Rao is a seasoned professional in the biotechnology and pharmaceutical sectors, currently serving as the VP of Business Development at Rondo Therapeutics since October 2023. Prior to this, Meghana held various roles at Johnson & Johnson, including Director of Early Innovation Partnering from January 2020 to September 2023, and contributed to Syneos Health as an Engagement Manager and Senior Consultant. Early career experiences include consulting positions at inVentiv Health and a Business Analyst internship at Deallus Consulting. Meghana's research background includes significant achievements during a PhD program in Cancer Biology at Vanderbilt University, where a $100,000 NIH grant was awarded to explore breast cancer progression. Additionally, Meghana's experience encompasses editorial work at The Company of Biologists and research at The Gladstone Institutes, focusing on diabetes mechanisms. Educational qualifications include a PhD from Vanderbilt University and a BS from UC San Diego.